Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bromocriptine for type 2 diabetes treatment
IRCT201204156710N3Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- May 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of bromocriptine in type 2 diabetes mellitus (T2DM), sponsored by Tabriz University of Medical Sciences. Started May 2012; status: completed.
02
Drugs
bromocriptine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on IRCT201204156710N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201204156710N3.